chrisvoncsefalvay/vaers-outcomes huggingface dataset:
convulsions; very high fever; This spontaneous report has been received from a patient's father via Pfizer concerning a female patient of unknown age (reported as when she was younger). The patient's concurrent conditions, medical history and concomitant medications were not reported.    On an unknown date, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (manufacturer unknown) (strength, dose, frequency, route, lot number and expiration date were not reported) for prophylaxis.    On an unknown date, the patient had a bad reaction including a very high fever and convulsions. She never received the second dose of the Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (manufacturer unknown) due to this reaction. The patient had recovered from the events on unknown dates.  The reporter and his wife were told that the patient did not actually have a reaction to the Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (manufacturer unknown) itself but that she already had immunity that was passed through to her by her mother and that was what caused her to have a reaction to the first dose of the Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (manufacturer unknown) (causality was entered as related conservatively).    Upon internal review, the event convulsions was determined to be medically significant.
injection site redness; injection site heat; area around the injection was raised; sore arm; left thumb locked,having problems with her left thumb; move left thumb with some discomfort; This spontaneous case was reported by a nurse and describes the occurrence of MYALGIA (sore arm), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE WARMTH (injection site heat), VACCINATION SITE SWELLING (area around the injection was raised) and TRIGGER FINGER (left thumb locked,having problems with her left thumb) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939906) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypercholesteremia, Facial spasm (right facial spasms since the shingles ) and Nerve damage (She did have shingles of the trigeminal nerve and had post traumatic nerve damage around her eye). Concomitant products included BOTULINUM TOXIN TYPE A (BOTOX) for Facial spasm, ATORVASTATIN CALCIUM (LIPITOR) for Hypercholesteraemia, GABAPENTIN (GRALISE) for an unknown indication.    On 11-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Sep-2021, the patient experienced MYALGIA (sore arm). On 12-Sep-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE WARMTH (injection site heat) and VACCINATION SITE SWELLING (area around the injection was raised). In September 2021, the patient experienced TRIGGER FINGER (left thumb locked,having problems with her left thumb) and DISCOMFORT (move left thumb with some discomfort). On 14-Sep-2021, MYALGIA (sore arm), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE WARMTH (injection site heat) and VACCINATION SITE SWELLING (area around the injection was raised) outcome was unknown. At the time of the report, TRIGGER FINGER (left thumb locked,having problems with her left thumb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   She also got sick after the Shingrix vaccine. no treatment medications were provided
Rash with associated itch developed roughly 10 days after receiving vaccine. I had similar symptoms about 2 weeks after my second dose that lasted for about 1 week. This time the symptoms are ongoing 16 days later.  The rash develops anywhere the skin is irritated and fades after about 30min.
Information has been received from a licensed practical nurse concerning a 60-day-old female who on 02-JAN-2007 was vaccinated PO with a 2ml dose of Rotateq (Lot # 655865/1109F). Concomitant therapy that day included a dose of PEDIARIX (Lot # AC218084CA administered IM, a dose of PedvaxHib (Lot # 654401/1015F) administered IM, and a dose of PREVNAR (Lot # B0867CA) administered IM. On 02-JAN-2007 the patient experienced bloody diarrhea, lethargy and anorexia. Subsequently, the patient recovered from bloody diarrhea, lethargy, and anorexia. The patient slept for 10 hours, and "was fine" the next day. The outcome was recovered. Upon internal review, bloody diarrhea was considered to be an other important medical event. Additional information has been requested.
Patient here for booster vaccine. Provider incorrectly ordered the 5-11yo Bivalent Booseter instead of the 12+ Bivalent Booster.  The CMA administering the vaccine did not catch the error in the order and administered the vaccine. No adverse health outcomes from receiving this vaccine. Provider spoke with mom over the phone today 12/21/22 and explained the error and recommended he return to the clinic 8-12 weeks after the bivalent booster was given for a nursing visit to receive the appropriate bivalent booster to be fully protected against COVID. Mom understood and said she and patient will return to the clinic sometime in February or receive the booster elsewhere if it is more convenient. COVID bivalent booster for ages 12 and up was ordered.
Patient became pale in face followed by pallor of (R) arm and (R) leg. Symptoms lasted less than 5 mins. No treatment,
Resident presenting today with facial swelling that extends from Chin into neck area. Redness to face.
Patient reported that after receiving the RSV vaccine (Arexvy) he began experiencing issues with his eye, stating that it is wondering to the side and he is also experiencing double vision. He has been to the doctor and was told that it was a nerve palsy that was causing it. He did not specify which eye.
Generalized allergic urticaria involving entire body without systemic symptoms (wheezing, cough, abdominal pain, vomiting, swelling) Rash originally was treated with  PO Benadryl but due to progression required oral steroid administration.
Pt was treated in the emergency department for pleuritic chest pain, pneumonia, and nonspecific left greater than right lower lobe ground glass opacities found on CT scan on February 27, 2021 beginning at 1826.
pt recv vax 8/17/98 & subsequently pt exp welts at inject site, urticaria lasting 15 min, & erythema. treated w/benadryl.
Vaccine was given on 1/28/23 and Td expired on 1/22/23. Pt did not have any adverse reactions as she monitored site vaccine was given in. She came back in a new vaccine was administered on 2/2/2023.
first vaccine was 2/26/20 / couldn't get the 2nd one in 6 months due to Covid shut down / get the 2nd one yesterday, 15 months later; This case was reported by a consumer via call center representative and described the occurrence of social problem in a 55-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 26th February 2020).   On 5th May 2021, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The patient did not get the 2nd dose in 6 months due to Covid shut down. The day before the reporting date, the patient received the 2nd dose, about 15 months later.  The patient asked he/she should consider that to be starting over with the first vaccine and plan a 2nd one in 2-6 months. No further information was reported.
Grand mal seizure started within 1 minute of vaccine administration. Patient had full body stiffness, eyes rolled back, urinated herself, and had a brief loss of consciousness. Seizure spontaneously resolved within 10 seconds and patient had a several minute post-ictal phase. I rolled patient onto her side and monitored her O2 sat in the post-ictal phase. Patient reported dizziness and nausea during this period.  EMS evaluated patient and recommended emergency evaluation, patient refused transport. Patient ambulated on her own out of the store after about 20 minutes.
The patient came to consultation today and said she got a shingrix vaccine and this was her second dose and the first dose was fine with no issues. She said a few days after the shingrix she developed  bumps on roof of mouth and top of mouth is raw and pallet is raw. The patient also has a sore on the top of her lips. She went to the doctor and the doctor gave her a prescription for antifungal which she filled. Thanked the patient for letting us know and apologized to the patient of what happened and the patient was fine and she was not worried and she just wanted us to know. The patient also let us know she is a nurse and she knows what to look out for and she is fine.
Information has been received from a health professional concerning a 5 year old male with seasonal allergies, and no other medical history, who on 17-OCT-2001 was vaccinated SC in the left leg with a 0.5 ml first dose of Varivax (lot # 638813/0239L). There was no concomitant medication. On 24-JUN-2006 the patient experienced over 40 lesions. The patient sought unspecified medical attention. At the time of the report the patient had not recovered. No product quality complaint was involved. Follow up information indicated that on 22-Jun-2006 the patient developed 40 lesions. The patient was seen for a doctor's visit. No further information was provided. No other information is expected.
Nausea, feverishness and chills started on Sunday morning, January 24th at around 2:30 AM. I was very pale and felt clammy, and the muscles in my upper arm, shoulder and neck were hurting more than just the normal ache from the shot. I had a hard time falling back asleep until I took more ibuprofen until the fever was gone. When the ibuprofen started to wear off I started to feel nauseous and fevered again, until I was able to take my next dose. I took 600 mg of ibuprofen every six hours for 24 hours to make the fever down to 99 degrees F. (My average body temperature is about 97.6 degrees F) At the time of this form I am still experiencing muscle pain, but it is more of a sore pain than the stabbing pain is had been on Sunday the 24th.
patient got RSV even though he was only 58 years all. no adverse even has been reported by the patient.
Pt recvd 1st dose of Hep B vax in MAY 1991 w/no adverse rxn; On 12JUN91 pt recvd 2nd dose of Hep B vax & 48 hrs p/vax exp body aches, joint pain, cough, anorexia, neck pain, back pain, weakness, chills & a fever of 103.2;
C/O stomach cramps and went to rest room without relief. Siting up on table sipping water.  Cramps still there however not any worse. School nurse in touch with parents and arranging for child to go home.
This spontaneous report was received from a physician via a company representative referring to a 17-year-old female patient. The patient's concurrent conditions, medical history, drug reactions, allergies, and concomitant medications were not reported. On 18-SEP-2018 the patient was vaccinated with GARDASIL 9, intramuscular for prophylaxis (dose, strength, lot number or expiration date not provided). On the same date, the patient passed out shortly after the application. It was reported that the patient sought medical attention for the event, as she was in the physician's office at the time of the event. The patient recovered from the event on an unknown period of time afterward. The causality assessment between the event and the vaccine was not reported. Upon internal review, the event was considered as medically significant.
Pt recv vax on 9/25/98; 1 hr post vax pt exp numbness in Rt arm & Rt leg x 5hr, inability to walk; tx=Motrin
This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 14:00 (at the age of 34-years-old) as a single dose for COVID-19 immunization. Medical history and allergic history to medications, food, or other products were reported as no. Concomitant medications included cetirizine hydrochloride (ZYRTEC), fluticasone propionate (FLONASE) and ibuprofen (MANUFACTURER UNKNOWN); all for unknown indication from an unspecified date. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 01770605) via an unspecified route of administration in the left arm on 06Mar2021 at 14:00 (at the age of 34-years-old) as a single dose for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 02:00, 36 hours after receiving second dose the patient experienced arm swollen at injection site and swelling was the size of an egg.  On 29Mar2021 at 14:00, 48 hours after receiving second dose, patient lower lip swelled up and 6 hours later the top lip started swelling up. Lip swelling started going down 24 hours after the start of each area. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events vaccination site swelling and lip swelling were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.
Patient experienced significant pain in his right shoulder following the Influenza vaccine and the pain radiates to the top of his shoulder, into the right side of his neck, jaw, and face. He has been taking Ibuprofen 400 mg a day for pain, with minimal relief. Patient has not seen a provider for this matter.
Bruise formed same day on 17 skin started peeling about 4 inches long raw and painful on 20th skin started to try to form on22nd it became raw again and bruise is forming around it peeling again went to doctor on 21 she said she has never seen anything like it she said measure it and come back if worse thinking about going to hospital no other symptoms or fevers
Large rash around the injection site; Injection site tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Large rash around the injection site) and VACCINATION SITE PAIN (Injection site tender) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Large rash around the injection site) and VACCINATION SITE PAIN (Injection site tender). At the time of the report, VACCINATION SITE RASH (Large rash around the injection site) and VACCINATION SITE PAIN (Injection site tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Pt had sudden onset of diaphoresis, pallor to face, left hand tingling and nausea @ 1135.BP 99/69, HR 78, RR 16, temp 97.8. Pt provided bottled water and consumed 2 bottles, tolerated well. Color returned to normal and no longer diaphoretic. Patient nausea and left hand tingling resolved.
left knee hurts; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Feb-2021 and was forwarded to Moderna on 23-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (left knee hurts) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No concomitant medications provided.  The patient's past medical history included Knee replacement.    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced ARTHRALGIA (left knee hurts). At the time of the report, ARTHRALGIA (left knee hurts) outcome was unknown.            Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: TCR Received: Consent to follow up denied
SERIOUSNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT.  Initial report received from another manufacturer (no case reference number provided) on 20 May 2008.  The other manufacturer received the case from the patient's parent.  A male patient of unspecified age developed seizures and asthma after he had received an injection of HIB vaccine on an unspecified date.  The trade name, manufacturer, and lot number were not provided.  It was reported that the manufacturer of the vaccine was "not Merck".  The patient's past medical history was not reported.  The patient has been experiencing seizures and asthma since the time of vaccination.  No further information was available from the reporter.
Hurts to raise arm; Neck is stiff; Body aches; Arm hurts; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Hurts to raise arm), MUSCULOSKELETAL STIFFNESS (Neck is stiff), MYALGIA (Body aches), VACCINATION SITE PAIN (Arm hurts) and HEADACHE (Headaches) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Hurts to raise arm), MUSCULOSKELETAL STIFFNESS (Neck is stiff), MYALGIA (Body aches), VACCINATION SITE PAIN (Arm hurts) and HEADACHE (Headaches). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Hurts to raise arm), MUSCULOSKELETAL STIFFNESS (Neck is stiff), MYALGIA (Body aches), VACCINATION SITE PAIN (Arm hurts) and HEADACHE (Headaches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up received on 20 Apr 2021. Updated reporter's email. On 02-Jun-2021: Follow up received on 02 Jun 2021. Updated outcome of the events.
severe headaches, nerve pain, shoulder blade pain, muscle aches, "effervescent" sensation in legs, knee pain
6 days after receiving the vaccine the patient developed a spotty rash in multiple places on my body. Patient is saying it is itching. I examined the patient today 2/12/2021 I prescribed Benadryl Cream and Benadryl tablets.
Coughing started approx. 20 minutes after receiving the vaccine. O2 was checked was at 99. patient reported throat swelling. Patient was transported via wheelchair to ER.
Information has been received from a health professional concerning an approximately 24 year old female pt with a history of Guillain Barre syndrome and latex sensitivity who in 2000 was vaccinated with a three dose series of hep b vaccine. Subsequently, in approximately 2001, the pt had a negative anti-HBs titer. On 08/14/2001 was vaccinated with a booster dose of hep b vaccine recombinant. On 08/14/2001 the pt developed a very sore arm, injection site swelling in the arm, tingling and numbness in her fingers and a very high fever of 105 F. The pt was seen on 08/29/2001, for a follow-up, and her only complaints were some tingling and numbness in her fingers. The pt also told the nurse that "she always develops a fever after receiving a vaccination." Unspecified medical attention was sought. Additional info has been requested. Follow up info indicated that the pt has a history of "similar reactions to previous vaccines." It was also noted that she was paralyzed for 4.5 months from the neck down as a child and "subsequently develops fever with all vaccines." It was reported that the pt fuly recovered on 8/14/01.
Case number PHEH2014US003591 is an initial spontaneous report received from a pharmacist on 21 Feb 2014. This report refers to a 16-year-old female patient. The patient's medical history and concomitant medications were not reported. This patient under the age of 18 years was vaccinated with 0.5 ml of FLUCELVAX (batch number: unknown) intramuscularly on 29 Nov 2013. No adverse event was reported following this medication error. Following an internal review on 18 Aug 2014, a significant correction was done for the information received on 21 Feb 2014: The BPI labeling of the event "Inappropriate age at vaccine administration" changed from listed to unlisted and added second indication as "drug use in unapproved population".
pt reports redness, itching, blisters on fingers on both hands, about a week and half after receiving moderna covid vaccine and believes it was a delayed reaction to the vaccine
Awoke today with a splotchy rash/mark around the injection site. The site where the injection occurred is centered in the rash. There is an additional mark/rash about 2 inches below and to the slight left of the injection site mark/rash. Both sites are the same temperature as the rest of my body, not additional symptoms, it?s just visual.
pt recv vax JUN96 & for the past 2 to 3 months pt has been exp a low grade fever, malaise, n/v, & diarrhea;pt has tested positive for HbSAg levels & negative for elevation in liver enzymes;pt was in Indonesia for 1yr prior to APR97;
cold, clammy, pale-pupils dialted-abdo crmaping-BP 80/36 pulse rapid observed for 10 mins-circumoral cyanosis-.25cc Epi;
This care was reported by a pharmacist and described the occurrence of chronic inflammatory demyelinating polyneuritis in a 68 year old female who was vaccinated with Twinrix for prophylaxis. The pt's medical history, concurrent conditions, and concurrent medications were not reported. On an unspecified date, the pt received an injection of Twinrix (234A6). At an unspecified time post-immunization, the pt experienced chronic inflammatory demyelinating polyneuritis. The event was unresolved as of 6/4/03. Chronic inflammatory demyelinating polyneuritis is considered medically serious (OMIC).
Very nauseous, light headedness, passed out, Chills for the entire night. Had to call 911 to be seen by paramedics.
Rash starting under the breast area around to the side and up to the armpit on both sides of body
Patient stated that almost immediately after the shot, she had a feeling of pain going down her left arm in what the doctor described as the distribution of the radial nerve.  The patient also described that her arm felt heavier, there was tingling in her thumb, the front and back of her arm hurt.  She said she could not hold a cup or book in her left hand.  Also arm was hard to straighten.  She had EMG studies and physical therapy.  In May 2009 she continued to complain of pain and was referred for an electrodiagnostic medicine consult in June 2009.